News

Stirling Square Capital Partners (“Stirling Square”), a leading pan-European mid-market private equity firm, today announces that it has sold Vision Ophthalmology Group (“VOG”) to AddLife AB, a listed Medical Technology company headquartered in Sweden focused on the distribution of healthcare products.

VOG is a leading independent European distributor of high-quality solutions for ophthalmic surgery, providing products and services related to eye surgeries such as cataract and glaucoma treatments.

The transaction represents Stirling Square’s Third Fund’s third realisation to date.